Multimodal evoked potentials measure and predict disability progression in early relapsing-remitting multiple...

Area of Science:

• Neuroscience
• Clinical Neurology
• Biomedical Engineering

Background:

• Early relapsing-remitting multiple sclerosis (RRMS) requires sensitive measures for disease activity monitoring.
• Clinical scores like EDSS and MSFC assess disability but may lag behind underlying pathology.

Purpose of the Study:

• To evaluate the utility of serial multimodal evoked potential scores (mEPS) in assessing disease activity in early RRMS.
• To determine if mEPS can predict clinically relevant disease progression over 24 months.

Main Methods:

• Prospective study of 37 early RRMS patients over 24 months.
• Collected serial multimodal evoked potential scores (mEPS), Expanded Disability Status Scale (EDSS), and multiple sclerosis functional composite (MSFC).
• Analyzed correlations between changes in mEPS and clinical scores.

Main Results:

• Changes in mEPS significantly correlated with changes in EDSS (rho = 0.69) and MSFC (rho = -0.41).
• Patients with significant EDSS progression showed greater mEPS deterioration compared to stable patients (p < 0.005).
• Baseline mEPS predicted EDSS at 24 months (rho = 0.39).

Conclusions:

• Serial mEPS measurements are valuable for monitoring disease activity in early RRMS.
• mEPS serves as a potential predictive biomarker for clinically relevant disease progression in early MS.
• This neurophysiological measure aids in understanding disease dynamics in the therapeutically critical early stage of RRMS.